CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Novartis AG

NVS
$274.68B
Mega Cap
NYSEBiotechnology🇨🇭Europe75.9K employees
Website

Drugs in Pipeline

724

Phase 3 Programs

433

Upcoming Catalysts

32

Next Catalyst

Mar 27, 2026

20d

Market Overview

Stock performance and key metrics

NVS News
Catalyst Timeline

34 upcoming, 5 past

No catalysts found.

34 more catalysts beyond 14 days

Start a 48h free trial to see all upcoming catalysts

Pro
Drug Pipeline

Cell-Derived Trivalent Subunit Influenza Vaccine Lot 1 (cTIV)

Phase 3

Influenza

Olmesartan

Phase 3

Essential Hypertension

Fingolimod

Phase 3

Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Ceritinib

Phase 3

ALK-positive Non-small Cell Lung Cancer

vinorelbine

Phase 3

HER2/Neu Over-expressing Locally Advanced Breast Cancer

Hydrochlorothiazide

Phase 3

Hypertension

Monovalent A/H1N1 influenza vaccine

Phase 3

Pandemic Influenza

Terbinafine hydrochloride (HCl)

Phase 3

Tinea Capitis

MenACWY-CRM197 (two doses)

Phase 3

Meningococcal Meningitis

Iptacopan (LNP023)

Phase 3

Paroxysmal Nocturnal Hemoglobinuria (PNH)

MenACWY-CRM conjugate vaccine

Phase 3

Meningococcal Meningitis

Zoledronic acid 4 mg

Phase 3

Non-Small-Cell Lung Cancer

Indacaterol 300 μg

Phase 3

Asthma

Cell culture-derived influenza vaccine

Phase 3

Influenza

Licarbazepine

Phase 3

Bipolar I Disorder

sitagliptin

Phase 3

Diabetes Mellitus, Type 2

Aliskiren

Phase 3

Hypertension

Pelacarsen (TQJ230)

Phase 3

Atherosclerotic Cardiovascular Disease

Secukinumab

Phase 3

Psoriatic Arthritis

AIN457

Phase 3

Behcet Disease

Everolimus

Phase 3

Kidney Transplantation

Fulvestrant

Phase 3

Breast Cancer

AAA617

Phase 3

Oligometastatic Prostate Cancer (OMPC)

[18F]CTT1057

Phase 3

Prostatic Neoplasms

ranibizumab

Phase 3

Choroidal Neovascularization

TIV1c

Phase 3

Influenza

NVA237

Phase 3

Chronic Obstructive Pulmonary Disease

Valsartan

Phase 3

Hypertension

cyclosporine

Phase 3

de Novo Kidney Transplant Recipients

Octreotide LAR

Phase 3

Somatostatin Receptor Positive (SSTR+)

Zoledronic acid

Phase 3

Cancer Prostate

Glimepiride

Phase 3

Diabetes Mellitus, Type 2

secukinumab 150 mg

Phase 3

Moderate to Severe Plaque-type Psoriasis

QVA149

Phase 3

Chronic Obstructive Pulmonary Disease (COPD)

Bexsero® vaccine (1 dose at study month zero)

Phase 3

Meningoccocal Disease

Meningococcal B Recombinant + Outer Membrane Vesicle vaccine (rMenB+OMV NZ)

Phase 3

N. Meningitidis Carriage

secukinumab 300 mg

Phase 3

Moderate to Severe Palmoplantar Psoriasis

DTaP-IPV-HBV

Phase 3

Meningitis, Meningococcal

Paclitaxel

Phase 3

Breast Cancer

Focalin XR

Phase 3

ADHD

Brolucizumab

Phase 3

Diabetic Macular Edema

BYM338/bimagrumab

Phase 3

Sporadic Inclusion Body Myositis

Vildagliptin

Phase 3

Diabetes Mellitus, Type 2

MF59-eH1N1_f

Phase 3

Influenza

Sildenafil

Phase 3

Mild to Moderate Hypertension

DTaP-IPV/Hib

Phase 3

Meningococcal Disease

Metformin

Phase 3

Diabetes Mellitus, Type 2

Ianalumab

Phase 3

Warm Autoimmune Hemolytic Anemia (wAIHA)

Artemether-lumefantrine

Phase 3

Malaria

Brolucizumab 6 mg

Phase 3

Proliferative Diabetic Retinopathy

FTY720

Phase 3

Renal Transplantation

secukinumab 150mg

Phase 3

Plaque-type Psoriasis

Depiquick Birch (DPG103)

Phase 3

Allergic Rhinoconjunctivitis

MenACWY CRM

Phase 3

Meningococcal Infections

Influenza vaccine

Phase 3

Influenza

Indacaterol

Phase 3

Chronic Obstructive Pulmonary Disease

agomelatine

Phase 3

Major Depressive Disorder

Diclofenac sodium gel 1%

Phase 3

Muscle Soreness

Imatinib

Phase 3

Chronic Myeloid Leukemia

rMenB + OMV NZ vaccine

Phase 3

Meningococcal Disease

Vaxem Hib (Haemophilus influenzae type b (Hib) vaccine)

Phase 3

Haemophilus Influenzae Type b (Hib) Infection

Tetanus toxoid vaccine

Phase 3

Relapsing Multiple Sclerosis

Ritalin LA (methylphenidate hydrochloride extended release)

Phase 3

Attention Deficit/Hyperactivity Disorder

Fevipiprant 150 mg

Phase 3

Nasal Polyps

LMF237 50/250 mg

Phase 3

Diabetes Mellitus, Type 2

Tifacogin

Phase 3

Pneumonia

indacaterol and glycopyrronium bromide (QVA149)

Phase 3

COPD

Indacaterol 150 μg

Phase 3

Chronic Obstructive Pulmonary Disease

eltrombopag

Phase 3

Thrombocytopaenia

Sorafenib

Phase 3

Metastatic Renal Cell Carcinoma

Salmeterol/fluticasone (50/500 μg)

Phase 3

Chronic Obstructive Pulmonary Disease

Cyclosporine A microemulsion

Phase 3

Chronic Plaque Psoriasis

TIVc_LOT A

Phase 3

Prophylaxis: Influenza

Diclofenac Sodium Gel

Phase 3

Osteoarthritis of the Knee

valsartan+amlodipine combination, valsartan, amlodipine

Phase 3

Hypertension

1 dose of Meningococcal (group B) multicomponent recombinant adsorbed vaccine

Phase 3

Meningococcal Disease

RTH258

Phase 3

Neovascular Age Related Macular Degeneration

Tamoxifen

Phase 3

Advanced Metastatic Breast Cancer

OFC Infusion

Phase 3

Leukaemia, Lymphocytic, Chronic

rabies vaccine

Phase 3

Rabies Post-exposure Prophylaxis

Cell derived subunit trivalent nonadjuvanted vaccine

Phase 3

Influenza

irbesartan

Phase 3

Hypertension

Enteric-coated Mycophenolate sodium (EC-MPS), valsartan

Phase 3

De Novo Renal Transplantation

Active Comparator

Phase 3

Alzheimer's Disease

EC-MPS

Phase 3

Patients Successfully Completing the 12-month Treatment Period of the Core Study (de Novo Heart Recipients) Who Were Interested of Being Treated With EC-MPS

Brolucizumab 6mg

Phase 3

Neovascular Age-Related Macular Degeneration

Ruxolitinib (RUX)

Phase 3

Corticosteroid Refractory Acute Graft vs Host Disease

Canakinumab 150 mg

Phase 3

Acute Gout

GP2017 (adalimumab biosimilar)

Phase 3

Ankylosing Spondylitis

Labeled regime arm

Phase 3

Diabetic Macular Edema

Long-acting beta 2-agonist (LABA)

Phase 3

Chronic Obstructive Pulmonary Disease (COPD)

Valsartan + Amlodipine besilate

Phase 3

Hypertension

Budesonide

Phase 3

Asthma

Mycophenolic Acid (MPA)

Phase 3

Kidney Transplantation

First line DMT

Phase 3

Multiple Sclerosis

Iptcaopan 200 mg

Phase 3

Atypical Hemolytic Uremic Syndrome

Meningococcal B Recombinant vaccine rMenB+OMV NZ

Phase 3

Meningococcal Disease

Everolimus and tacrolimus

Phase 3

Kidney Transplant

Risedronate

Phase 3

Paget's Disease of Bone

Pimecrolimus Cream 1%

Phase 3

Atopic Dermatitis

Daptomycin

Phase 3

Infections

Salmeterol

Phase 3

Chronic Obstructive Pulmonary Disease

sacubitril/valsartan

Phase 3

Heart Failure With Preserved Ejection Fraction

Octreotide

Phase 3

Thymoma

Enalapril

Phase 3

Pediatric Heart Failure

valsartan plus hydrochlorothiazide

Phase 3

Hypertension

NVA237 50 µg and indacaterol 150 µg

Phase 3

Chronic Obstructive Pulmonary Disease (COPD)

ciclosporin

Phase 3

Severe Atopic Dermatitis

rofecoxib

Phase 3

Osteoarthritis

sulfonylurea (SU)

Phase 3

Type 2 Diabetes Mellitus (T2DM)

MF59-eH1N1

Phase 3

Influenza

MF59 adjuvanted trivalent subunit influenza vaccine (aTIV)

Phase 3

Influenza

octreotide LAR 30mg

Phase 3

Acromegaly

basiliximab

Phase 3

Liver Transplantation

valsartan+amlodipine combination

Phase 3

Hypertension

Remibrutinib

Phase 3

Relapsing Multiple Sclerosis

Telbivudine

Phase 3

Hepatitis B Virus

Depigoid

Phase 3

Allergic Asthma

Secukinumab (75 mg)

Phase 3

Ankylosing Spondylitis

onasemnogene abeparvovec

Phase 3

Spinal Muscular Atrophy (SMA)

Leuprolide

Phase 3

Breast Cancer

brolucuzumab 6 mg IVT

Phase 3

Age-Related Macular Degeneration

Ofatumumab

Phase 3

Relapsing Multiple Sclerosis

Deferasirox

Phase 3

Beta-thalassemia

ACZ885 150 mg (Canakinumab)

Phase 3

Systemic Juvenile Idiopathic Arthritis (SJIA)

canakinumab

Phase 3

NALP3 Mutation

Candesartan+HCTZ - Phase 1

Phase 3

Hypertension

Ansastrozole

Phase 3

Early Breast Cancer

Aliskiren/amlodipine 300/10 mg tablet

Phase 3

Moderate to Severe Hypertension

Verteporfin photodynamic therapy

Phase 3

Macular Degeneration

Glycopyrronium bromide

Phase 3

Chronic Obstructive Pulmonary Disease

LOU064 25 mg (b.i.d)

Phase 3

Chronic Spontaneous Urticaria

Fluvastatin

Phase 3

Heterozygous Familial Hypercholesterolemia

indacaterol and glycopyrronium (QVA149)

Phase 3

Chronic Obstructive Pulmonary Disease (COPD)

Pasireotide LAR

Phase 3

Acromegaly

pioglitazone

Phase 3

Diabetes Mellitus, Type 2

Indacaterol acetate/Mometasone furoate

Phase 3

Asthma

glycopyrronium (NVA237)

Phase 3

Chronic Obstructive Pulmonary Disease (COPD)

CTL019

Phase 3

B-cell Acute Lymphoblastic Leukemia

Paracetamol (500 mg)/dimethindene maleate (1 mg)/ phenylephrine hydrochloride (10 mg) tablets

Phase 3

Upper Respiratory Tract Infection

interferon-alpha (INF-a)

Phase 3

Chronic Myelogenous Leukemia

QMF149 150/80 μg

Phase 3

Mild Asthma

RLX030

Phase 3

Chronic Heart Failure (CHF)

Secukinumab (AIN457)

Phase 3

Psoriatic Arthritis

Remibrutinib Dose A

Phase 3

Hidradenitis Suppurativa

HCQ

Phase 3

Covid-19

Tegaserod

Phase 3

Heartburn

valsartan 160 mg

Phase 3

Chronic Heart Failure

letrozole

Phase 3

Breast Cancer

Haemophilus influenzae type b (Hib) vaccine

Phase 3

Haemophilus Influenzae Type b (Hib) Infection

Meningococcal (groups A, C, W, and Y) oligosaccharide diphtheria CRM-197 conjugate vaccine

Phase 3

Meningococcal Meningitis

ICL670

Phase 3

Transfusional Iron Overload

sunitinib

Phase 3

Renal Cell Carcinoma

MenACWY-CRM + MMRV

Phase 3

Meningococcal Infections

Indacaterol 150 µg

Phase 3

Chronic Obstructive Pulmonary Disease

QIVc

Phase 3

Influenza

Lumiracoxib

Phase 3

Osteoarthritis

eH1N1_f

Phase 3

Novel 2009 Influenza H1N1

Monovalent glyco-conjugated vaccine against Haemophilus influenzae type b (Hib)

Phase 3

Haemophilus Influenzae Type b (Hib) Infection

Valsartan/amlodipine 160/5 mg

Phase 3

Essential Hypertension

Cell culture derived seasonal trivalent influenza vaccine (cTIV)

Phase 3

Influenza

cTIV

Phase 3

Seasonal Influenza Vaccine

etanercept

Phase 3

Chronic Plaque Psoriasis

lisinopril

Phase 3

Hypertension

TQJ230

Phase 3

Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease

Dexmethylphenidate HCl extended-release capsules

Phase 3

ADHD, ADD

Trivalent split influenza vaccine (TIV)

Phase 3

Influenza Disease

preservative free inactivated split influenza vaccine using the strain composition 2006/2007

Phase 3

Influenza

LCZ696

Phase 3

Heart Failure

Amlodipine 5 mg

Phase 3

Hypertension

Valsartan 0.25 mg/kg

Phase 3

Hypertension

rMenB+OMV NZ

Phase 3

Meningococcal Disease

TIVc

Phase 3

Human Influenza

Rabies vaccines + Rabies immunoglobulins

Phase 3

Rabies Infection

Meningococcal ACWY conjugate vaccine (MenACWY-CRM)

Phase 3

Meningococcal Disease

onasemnogene abeparvovec-xioi

Phase 3

Spinal Muscular Atrophy

No Vaccine

Phase 3

Meningococcal Disease

Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2010/2011

Phase 3

Seasonal Influenza

Novartis MenACWY-CRM

Phase 3

Meningococcal Disease

Rivastigmine Transdermal Patch

Phase 3

Alzheimer's Disease

Zagreb

Phase 3

Rabies

Metformin Comparator

Phase 3

Diabetes Mellitus, Type 2

Haemophilus influenzae type b vaccine

Phase 3

Haemophilus Influenzae Type b

Pazopanib

Phase 3

Solid Tumours

Lot A of Influenza virus vaccine

Phase 3

Influenza

Aliskiren (6.25/12.5/25 mg)

Phase 3

Hypertension

Routine Vaccines

Phase 3

Meningococcal Disease

LOU064

Phase 3

Chronic Spontaneous Urticaria

QMF149

Phase 3

Asthma

FTY 720

Phase 3

Kidney Transplantation

Lamivudine

Phase 3

Hepatitis

TIVf

Phase 3

Human Influenza

Adjuvanted cell-derived, inactivated novel swine origin A/H1N1 monovalent subunit influenza virus vaccine

Phase 3

Influenza

AAA817

Phase 3

Prostate Cancer

Hib-CRM197

Phase 3

Meningitis, Epiglottitis, Pneumonia, Arthritis Caused by Haemophilus Influenzae Type b

Valsartan + amlodipine 40/2.5 mg

Phase 3

Essential Hypertension

177Lu-PSMA-617

Phase 3

Prostatic Neoplasms

AIN457 (secukinumab)

Phase 3

Psoriatic Arthritis

Inclisiran Sodium

Phase 3

ASCVD

Introduction of everolimus with reduced cyclosporine or tacrolimus dose, the earliest 1 month and the latest 6 months after liver transplantation.

Phase 3

Renal Function

Remibrutinib (Open Label)

Phase 3

Generalized Myasthenia Gravis

Aliskiren/HCTZ

Phase 3

Hypertension

Inclisiran sodium 300 mg

Phase 3

Coronary Artery Disease

eltrombopag olamine (SB-497115-GR)

Phase 3

Purpura, Thrombocytopaenic, Idiopathic

Secukinumab 300mg

Phase 3

Palmoplantar Pustular Psoriasis

Imatinib mesilate

Phase 3

Refractory Desmoplastic Small Round Cell Tumors

Canakinumab 150mg in prefilled syringe

Phase 3

Acute Gouty Arthritis

Agomelatine (AGO178C)

Phase 3

Major Depressive Disorder

Iptacopan

Phase 3

Glomerulonephritis, IGA

Secukinumab 150 mg provided in 1.0 mL pre-filled syringes (PFSs) for sc injection.

Phase 3

Ankylosing Spondylitis

Adjuvanted influenza vaccine

Phase 3

Influenza Disease

Meningococcal ACWY-CRM conjugate vaccine

Phase 3

Meningococcal Disease

BEGRIVAC

Phase 3

Seasonal Influenza

1a - rMenB+OMV NZ and routine vaccines

Phase 3

Meningococcal Disease

formoterol

Phase 3

Asthma

Influenza Virus Vaccine

Phase 3

Influenza Disease; Flu

capecitabine

Phase 3

Metastases, Brain

Adjuvanted seasonal influenza vaccine

Phase 3

Influenza

Alpelisib

Phase 3

Advanced Breast Cancer

Experimental : Secukinumab low dose

Phase 3

Chronic Severe Plaque-type Psoriasis

Trivalent influenza virus vaccine (TIVf)

Phase 3

Human

AMN107

Phase 3

Gastrointestinal Stromal Tumors

Terbinafine

Phase 3

Tinea Pedis

CDZ173

Phase 3

Common Variable Immunodeficiency (CVID), APDS / PASLI

Everolimus (RAD001)

Phase 3

Tuberous Sclerosis Complex (TSC)

tacrolimus

Phase 3

Liver Transplantation

Valsartan + Hydrochlorothiazide

Phase 3

Hypertension

dovitinib

Phase 3

Hepatocellular Carcinoma

Aliskiren 150/300 mg

Phase 3

Hypertension

Bimagrumab

Phase 3

Sporadic Inclusion Body Myositis

Remibrutinib (blinded)

Phase 3

Secondary Progressive Multiple Sclerosis (SPMS)

Meningococcal C conjugate vaccine

Phase 3

Prevention of Meningococcal Infection

Cell culture-derived trivalent subunit influenza vaccine (cTIV)

Phase 3

Influenza

canakinumab (company code: ACZ885D)

Phase 3

Cryopyrin Associated Periodic Syndrome

Siponimod

Phase 3

Multiple Sclerosis

Everolimus + Cyclosporine

Phase 3

Renal Transplantation

Darifenacin

Phase 3

Overactive Bladder Syndrome

Umeclidinium/vilanterol

Phase 3

Chronic Obstructive Pulmonary Disease

Salmeterol 50 µg

Phase 3

Chronic Obstructive Pulmonary Disease (COPD)

telbivudine or lamivudine

Phase 3

Chronic Hepatitis B

rMenB+OMV NZ with routine vaccinations

Phase 3

Meningococcal Disease

Sham to ranibizumab

Phase 3

Diabetic Macular Edema

Typhoid Vi Polysaccharide Vaccine

Phase 3

Meningococcal Disease

vildagliptin + metformin

Phase 3

Diabetes Mellitus, Type 2

NVA237 50µg once daily

Phase 3

Chronic Obstructive Pulmonary Disease

Secukinumab 2 mL form

Phase 3

Psoriasis

Osilodrostat

Phase 3

Cushing's Syndrome

Everolimus 0.25 and 0.75 mg tablets

Phase 3

Transplantation Infection

Amlodipine 10 mg

Phase 3

Hypertension

BAF312

Phase 3

Secondary Progressive Multiple Sclerosis

ABL001 40mg BID

Phase 3

Chronic Myelogenous Leukemia

Cyclosporine (Neoral)

Phase 3

Organ Transplantation, Renal Transplantation

Inclisiran Sodium for injection

Phase 3

Homozygous Familial Hypercholesterolemia

paroxetine

Phase 3

Major Depressive Disorder

salbutamol/albuterol

Phase 3

Chronic Obstructive Pulmonary Disease

Ianalumab (VAY736)

Phase 3

Sjogrens Syndrome

Myfortic

Phase 3

Kidney Transplantation

Rivastigmine Patch

Phase 3

Alzheimer's Disease

Abbreviated Zagreb 2-1-1 schedule

Phase 3

Rabies

mycophenolate mofetil

Phase 3

Graft Rejection

QAB149

Phase 3

COPD

Valsartan 160 mg + nateglinide 60 mg

Phase 3

Diabetes Mellitus, Type 2

valsartan + simvastatin

Phase 3

HYPERTENSION

Ranibizumab 0.3 mg - 3 times monthly, then quarterly

Phase 3

Age Related Macular Degeneration

NVA237 (glycopyrronium bromide)

Phase 3

Asthma

imatinib mesylate

Phase 3

Leukemia

Diclofenac sodium

Phase 3

Acute Blunt Soft Tissue Injuries/Contusions

Lapatinib (GW572016) oral tablets

Phase 3

Neoplasms, Breast

Novartis Meningococcal ACWY Conjugate Vaccine

Phase 3

Meningococcal Meningitis

Secukinumab/Adalimumab-Biosimilar

Phase 3

Axial Spondyloarthritis

Atenolol

Phase 3

Hypertension

Meningococcal (group B) multicomponent recombinant adsorbed vaccine

Phase 3

Meningitis, Meningococcal, Serogroup B

Clozapine

Phase 3

Schizophrenia

indacaterol maleate

Phase 3

Asthma

Valsartan/amlodipine 80/5 mg

Phase 3

Hypertension

Diclofenac Topical Sodium Gel 1%

Phase 3

Osteoarthritis

Pasireotide

Phase 3

Cushing Disease

Aliskiren/hydrochlorothiazide (HCTZ) (300/25 mg)

Phase 3

Hypertension

ianalumab s.c. q4w

Phase 3

Lupus Nephritis

Crizanlizumab

Phase 3

Sickle Cell Disease

Best Available Therapy

Phase 3

Polycythemia Vera

basiliximab, MMF(mycophenolate mofetil), cyclosporine, prednisone (or equivalent)

Phase 3

Pediatric Kidney Transplantation

Valsartan and simvastatin

Phase 3

Hypertension

Pelacarsen (TQJ230) 80 mg s.c.

Phase 3

Hyperlipoproteinemia(a)

AIN457 150mg

Phase 3

Moderate to Severe Plaque-type Psoriasis

[68Ga]Ga-DOTA-TATE

Phase 3

Neuroendocrine Neoplasms

asciminib

Phase 3

Leukemia, Chronic Myelogenous

Fingolimod 1.25 mg

Phase 3

Relapsing-remitting Multiple Sclerosis

Benazepril plus hydrochlorothiazide

Phase 3

Hypertension

LCQ908

Phase 3

Non-alcoholic Fatty Liver Disease (NAFLD)

Everolimus (Certican)

Phase 3

Heart Transplantation

Aflibercept 2 mg

Phase 3

Neovascular Age-related Macular Degeneration

Certican®

Phase 3

Renal Interstitial Fibrosis

Verteporfin PDT

Phase 3

Pathological Myopia

Pemetrexed

Phase 3

Non-Small Cell Lung Cancer

[68Ga]Ga-PSMA-11

Phase 3

Prostatic Neoplasms

AIN457 300 mg

Phase 3

Chronic Plaque Type Psoriasis

Vemurafenib

Phase 3

Melanoma

Chemotherapy

Phase 3

Acute Myeloid Leukemia (AML)

Indacaterol 150 μg capsules

Phase 3

Chronic Obstructive Pulmonary Disease (COPD)

VALSARTAN, VALSARTAN+HYDROCHLOROTHIAZIDE

Phase 3

Hypertension

Pelacarsen

Phase 3

Hyperlipoproteinemia (a)

Eltrombopag Tablets

Phase 3

Purpura, Thrombocytopenic, Idiopathic

Dabrafenib

Phase 3

Melanoma

Teriflunomide capsule

Phase 3

Relapsing Multiple Scelrosis

Tobramycin inhalation powder

Phase 3

Pseudomonas Aeruginosa

Tiotropium 18 μg

Phase 3

Chronic Obstructive Pulmonary Disease

TIV

Phase 3

Seasonal Influenza

Pertuzumab

Phase 3

Advanced HER2+Breast Cancer

AIN457 6 mg/kg i.v.

Phase 3

Psoriatic Arthritis

Pelabresib

Phase 3

Hematologic Malignancy

Midostaurin

Phase 3

FLT3-mutated Acute Myeloid Leukemia

Methylphenidate hydrochloride

Phase 3

ADHD

Unfractionated Heparin

Phase 3

Thromboembolism

Cell culture derived influenza vaccine

Phase 3

Influenza

Rabies

Phase 3

Rabies

RAD001

Phase 3

Metastatic Renal Cell Carcinoma

Relaxin

Phase 3

Heart Failure, Congestive

Antiepileptic drug (1 to 3 only)

Phase 3

Tuberous Sclerosis Complex-associated Refractory Seizures

Taxotere

Phase 3

Non Small Cell Lung Carcinoma

Mammalian cell based flu vaccine

Phase 3

Influenza

Serogroup B meningococcal Vaccine lot 1 (rMenB Lot 1)

Phase 3

Serogroup B Meningococcal Meningitis

Combined inactivated hepatitis A & recombinant hepatitis B

Phase 3

Meningococcal Disease

Adjuvanted Trivalent Influenza Vaccine, 1 dose for non-naive subjects (day 1), two doses for naive subjects (day 1 and day 29)

Phase 3

Influenza

Carbidopa/levodopa/entacapone

Phase 3

Parkinson's Disease

secukinumab low dose

Phase 3

Moderate to Severe Chronic Plaque-type Psoriasis

Lanzoprazole

Phase 3

Heartburn

Aliskiren 75 mg

Phase 3

Hypertension

Bosentan

Phase 3

Pulmonary Arterial Hypertension

Famciclovir

Phase 3

Genital Herpes

Crizanlizumab (SEG101)

Phase 3

Sickle Cell Disease (SCD)

VAL489

Phase 3

Pediatric Hypertension With or Without CKD

MMF

Phase 3

Prevention of Acute Rejection in Paediatric Recipients of a Renal Transplant

Pimecrolimus

Phase 3

Atopic Dermatitis

INC424

Phase 3

Myelofibrosis

Ranibizumab 0.5mg

Phase 3

Visual Impairment Due to Choroidal Neovascularization (CNV) Secondary to Pathologic Myopia (PM)

valsartan + amlodipine

Phase 3

Hypertension

Rivastigmine

Phase 3

Vascular Dementia

Amlodipine

Phase 3

Essential Hypertension

Monovalent inactivated influenza vaccine

Phase 3

Pre-pandemic Influenza Vaccine

Ribociclib

Phase 3

Early Breast Cancer

Ranibizumab 0.5 mg

Phase 3

Macular Edema Secondary to Branch Retinal Vein Occlusion

Gliclazide

Phase 3

Diabetes Mellitus, Type 2

Ligelizumab

Phase 3

Chronic Spontaneous Urticaria

QVM149 150/50/160

Phase 3

Asthma

Ezetimibe

Phase 3

Hypercholesterolemia

Dupilumab

Phase 3

Chronic Spontaneous Urticaria (CSU)

Ramipril

Phase 3

Hypertension

Background lipid lowering therapy

Phase 3

Atherosclerotic Cardiovascular Disease

Vildagliptin 50 mg bid

Phase 3

Type 2 Diabetes Mellitus

QVM149

Phase 3

Asthma

Aflibercept

Phase 3

Diabetic Macular Edema

Hydroxyurea

Phase 3

Glioblastoma Multiforme

Valsartan + HCTZ

Phase 3

Hypertension

deferoxamine

Phase 3

Beta-Thalassemia

Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL

Phase 3

Primary Prevention of Atherosclerotic Cardiovascular Disease

LOU064 (blinded)

Phase 3

Chronic Spontaneous Urticaria

KLU156

Phase 3

Uncomplicated Plasmodium Falciparum Malaria

thiazolidinedione (TZD)

Phase 3

Diabetes Mellitus, Type 2

Vildagliptin 100 mg qd

Phase 3

Diabetes Mellitus, Type 2

tobramycin

Phase 3

Pseudomonas Infections

inactivated split influenza vaccine

Phase 3

Seasonal Influenza

LOU064 (open label)

Phase 3

Chronic Spontaneous Urticaria

Dexamethasone implant and sham injections

Phase 3

Visual Impairment

ABL001

Phase 3

Chronic Myelogenous Leukemia - Chronic Phase

Canakinumab (ACZ885)

Phase 3

Cryopyrin-Associated Periodic Syndromes

Goserelin

Phase 3

Breast Cancer

Ofatumumab approved dose

Phase 3

Relapsing Multiple Sclerosis (RMS)

Octreotide Long Acting Release

Phase 3

Chemotherapy-induced Diarrhea

Secukinumab 150 mg s.c.

Phase 3

Plaque Psoriasis

Tobramycin solution for inhalation 300 mg

Phase 3

Cystic Fibrosis

AIN457 150 mg

Phase 3

Moderate to Severe Chronic Plaque-Type Psoriasis

JDQ443

Phase 3

Non-Small Cell Lung Cancer

Zoledronic acid 5 mg solution

Phase 3

Osteoporosis

RTH258/Brolucizumab

Phase 3

Neovascular Age-Related Macular Degeneration

Remibrutinib oral treatment

Phase 3

Relapsing Multiple Sclerosis

Telbivudine (LdT)

Phase 3

Chronic Hepatitis B

Lumiracoxib (drug)

Phase 3

Osteoarthritis, Hip

Recombinant meningococcal B + OMV NZ

Phase 3

Meningococcal Disease

Cytarabine

Phase 3

Acute Myeloid Leukemia

ACZ885

Phase 3

TNF-receptor Associated Periodic Syndromes (TRAPS)

Heparin

Phase 3

Embolism

Lansoprazole

Phase 3

Heartburn

Meningococcal ACWY conjugate vaccine

Phase 3

Bacterial Meningitis

Fluticasone/salmeterol

Phase 3

Chronic Obstructive Pulmonary Disease

exemestane

Phase 3

Post Menopausal Breast Cancer

Nilotinib

Phase 3

Gastrointestinal Stromal Tumors

Seasonal Influenza Vaccine

Phase 3

Influenza

Inclisiran

Phase 3

Familial Hypercholesterolemia - Homozygous

Octreotide acetate 30 mg suspension

Phase 3

Acromegaly

Losartan

Phase 3

Hypertension; Hypertrophy, Left Ventricular

Calcium and vitamin D supplements

Phase 3

Paget's Disease of Bone

Xylometazoline

Phase 3

Common Cold

Aliskiren 300 mg

Phase 3

Hypertension

Meningococcal ACWY Polysaccharide Vaccine

Phase 3

Meningococcal Meningitis

Bosutinib

Phase 3

Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive

Rivastigmine 5 cm^2

Phase 3

Alzheimer Disease

Olaparib

Phase 3

Ovarian Cancer

Enteric-coated Mycophenolate Sodium

Phase 3

Autoimmune Disease

oxcarbazepine

Phase 3

Epilepsy

Trametinib

Phase 3

Cancer

Valsartan 160 mg capsules

Phase 3

Essential Hypertension

Omalizumab

Phase 3

Asthma

Minimisation of TAC

Phase 3

Liver Transplant

LCZ

Phase 3

Hypertension

Abatacept

Phase 3

Rheumatoid Arthritis

amlodipine/benazepril

Phase 3

Hypertension

Mycophenolate sodium

Phase 3

Kidney Transplantation

Triamcinolone acetonide 40 mg

Phase 3

Acute Gouty Arthritis Flares

EPO906 (Patupilone)

Phase 3

Ovarian Cancer

Best Available Therapy (BAT)

Phase 3

Myelofibrosis

Ritalin LA 20 mg

Phase 3

Attention Deficit/Hyperactivity Disorder

valsartan/amlodipine

Phase 3

Hypertension

Ofatumumab subcutaneous injection

Phase 3

Relapsing Multiple Sclerosis

Enteric-coated mycophenolate sodium (EC-MPS)

Phase 3

Renal Transplantation

DTwP-HepB-Hib Vaccine

Phase 3

Diphtheria

LNP023

Phase 3

IgA Nephropathy

Ali/Amlo 150/2.5 mg

Phase 3

Essential Hypertension

Trivalent influenza virus vaccine (TIV)

Phase 3

Pandemic Influenza Disease

Ruxolitinib

Phase 3

Primary Myelofibrosis (MF)

Tiotropium

Phase 3

Chronic Obstructive Pulmonary Disease

Lapatinib

Phase 3

Neoplasms, Breast

Fumaric acid

Phase 3

Psoriasis

Hydrochlorothiazide (HCTZ)

Phase 3

Hypertension

Ustekinumab

Phase 3

Plaque Psoriasis

MenACWY-CRM

Phase 3

Meningococcal Infections

diclofenac diethylamine gel 2.32%

Phase 3

Grade I/II Ankle Sprain

QAW039

Phase 3

Asthma

Cell culture-derived influenza subunit vaccine (cTIV)

Phase 3

Influenza

Secukinumab 300 mg, s.c.

Phase 3

Giant Cell Arteritis

Entecavir

Phase 3

Hepatitis B

Certoparin

Phase 3

Persistent Nonvalvular Atrial Fibrillation

Salmeterol 50 μg

Phase 3

Chronic Obstructive Pulmonary Disease (COPD)

Alcohol-free dexamethasone mouth rinse (Stomatitis sub-study)

Phase 2

Hormone Receptor Positive Breast Cancer

KRP203 - 1.2mg

Phase 2

Subacute Cutaneous Lupus Erythematosus

Zoledronic Acid; Letrozole

Phase 2

Breast Cancer

BYL719

Phase 2

Breast Cancer

Conventional Therapy

Phase 2

Non-infectious Intermediate Uveitis

Buparlisib

Phase 2

Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma

Surface Antigen, Inactivated, Adjuvanted, Influenza Vaccine, Formulation 2007-2008

Phase 2

Influenza

Meningococcal (group B) multicomponent recombinant adsorbed vaccine.

Phase 2

Meningococcal Disease

epothilone b

Phase 2

Ovarian Neoplasms

GSK2110183 (afuresertib)

Phase 2

Cancer

TMZ

Phase 2

Medulloblastoma

decitabine

Phase 2

Myelodysplastic Syndromes

QAV680

Phase 2

Seasonal Allergic Rhinitis

Midostaurin (PKC412)

Phase 2

Leukemia

VAK694; Alutard Avanz SQ

Phase 2

Seasonal Allergic Rhinitis

PTK787/ZK 222584

Phase 2

Von Hippel-Lindau Disease

Meningococcal (groups A, C, W, Y) oligosaccharide diphtheria CRM-197 conjugate combined with meningococcal (group B) multicomponent recombinant vaccine + OMV.

Phase 2

Invasive Meningococcal Disease

Panobinostat/LBH589

Phase 2

Refractory Leukemia

BION-1301 Single Dose

Phase 2

IgA Nephropathy

QAW039 capsules once daily for 28 days

Phase 2

Persistent Asthma

Mycophenolic Acid

Phase 2

Kidney Transplantation

tisagenlecleucel

Phase 2

Follicular Lymphoma

Eplerenone

Phase 2

Essential Hypertension

MenACWY-TT

Phase 2

Meningococcal Disease

RKI983A

Phase 2

Glaucoma

BKM120

Phase 2

PI3K Pathway Activated Tumors

225Ac-PSMA-R2

Phase 2

Prostate Cancer

Treosulfane

Phase 2

Prostate Cancer

Fluad H5N1 Pandemic Influenza Vaccine

Phase 2

Prophylaxis of Avian Influenza Vaccine

hATG

Phase 2

Aplastic Anemia

QGE031

Phase 2

Allergic Asthma

Seasonal flu vaccine

Phase 2

Seasonal Influenza

Adjuvant endocrine therapy

Phase 2

Breast Cancer

JSB462

Phase 2

Prostatic Cancer, Castration-Resistant

VAY736

Phase 2

Primary Sjogren Syndrome

indacaterol/glycopyrrolate

Phase 2

Chronic Obstructive Pulmonary Disease (COPD)

STI571 400 mg

Phase 2

Philadelphia Positive Chronic Myeloid Leukemia

combined diphtheria,tetanus,pertussis+polio+Hepatitis B+Haemophilus influenzae B vaccine

Phase 2

Meningococcal Infections

LTP

Phase 2

Healthy Volunteers, Pulmonary Arterial Hypertension

ITU512

Phase 2

Sickle Cell Disease

BYM338 active drug

Phase 2

Cachexia

Everolimus 10 mg

Phase 2

Islet Cell Carcinoma

LDK378

Phase 2

Non-Small Cell Lung Cancer

BEZ235 (Stage 1)

Phase 2

Pancreatic Neuroendocrine Tumors (pNET)

Deferasirox dispersable tablet (DT)

Phase 2

Transfusion-dependent Thalassemia

Aliskiren 3.125 mini-tablets

Phase 2

Hypertension

Bridging Therapy

Phase 2

Non-Hodgkin Lymphoma

Fluticasone 250 mcg

Phase 2

Asthma

75 µg indacaterol maleate (LB)

Phase 2

Asthma

Nazartinib

Phase 2

Advanced Solid Tumors Which Are cMET-dependent

KAF156

Phase 2

Uncomplicated Plasmodium Falciparum Malaria

Meningococcal B vaccine

Phase 2

Meningococcal Meningitis

Meningococcal Vaccine

Phase 2

Meningococcal Disease

LRX712

Phase 2

Osteoarthritis (OA)

MenABCWY+OMV

Phase 2

Meningococcal Disease

AFQ056 with L-dopa

Phase 2

Parkinson's Disease

Men ACWY CRM

Phase 2

Meningococcal Disease

68Ga-PSMA-11

Phase 2

Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Influenza Vaccine, Formulation 2008-2009

Phase 2

Seasonal Influenza

ICL670, deferoxamine

Phase 2

Anemia, Sickle Cell

AIN 457

Phase 2

Non-infectious Uveitis

rMenB

Phase 2

Meningococcal Disease

IGE025

Phase 2

Chronic Idiopathic Urticaria

Pelacarsen (TQJ230) 80mg

Phase 2

Aortic Stenosis

AQW051

Phase 2

Dyskinesias

MCS110

Phase 2

Pigmented Villonodular Synovitis

Omalizumab 75-375 mg

Phase 2

Chronic Urticaria

Three 1 mL doses of Rabies vaccine and two JE vaccine

Phase 2

Rabies

CJM112

Phase 2

Hidradenitis Suppurativa (Acne Inversa)

QAX028

Phase 2

Chronic Obstructive Pulmonary Disease

LAG525

Phase 2

Triple-negative Breast Cancer

CGF166

Phase 2

Unilateral Severe to Profound Hearing Loss OR Bilateral Severe to Profound Hearing Loss

DFV890

Phase 2

Coronary Heart Disease

CMK389

Phase 2

Atopic Dermatitis

Nilotinib followed by treatment-free

Phase 2

Chronic Myelogenous Leukemia

MF59 adjuvanted H5N1 influenza vaccine

Phase 2

Influenza

EYU688

Phase 2

Dengue

Deferasirox DFX, DT

Phase 2

Low and Int 1-risk Myelodysplastic Syndrome

DTIC

Phase 2

Melanoma

[68Ga]Ga-NeoB

Phase 2

Breast Cancer

AUY922

Phase 2

Non-small-cell Lung Cancer

Entacapone

Phase 2

Parkinson's Disease

TCH346

Phase 2

Amyotrophic Lateral Sclerosis

CSJ117

Phase 2

Pulmonary Disease, Chronic Obstructive

DII235

Phase 2

Lipoprotein Disorder

LEZ763

Phase 2

Type II Diabetes

Rabbit ATG

Phase 2

Aplastic Anemia

Indacaterol maleate 400 μg

Phase 2

Asthma

Deferasirox and Deferoxamine

Phase 2

Cardiac Iron Overload

STI571

Phase 2

Systemic Sclerosis, Scleroderma

SBR759

Phase 2

Hyperphosphatemia Patients With Chronic Kidney Disease on 3x/Week Replacement Therapy

Alum

Phase 2

Alzheimer's Disease

STI571 (Glivec®)

Phase 2

Prostatic Neoplasm

MenC-CRM LIQ

Phase 2

Meningococcal Disease

Secukinumab 10 mg/kg

Phase 2

Dry Eye

LEE011

Phase 2

Teratoma

EGF816

Phase 2

Advanced Non-small Cell Lung Cancer

CSJ148

Phase 2

HCMV

cyclosporine (reduced exposure) / everolimus

Phase 2

Kidney Transplantation

Simulect®

Phase 2

Renal Transplantation

AEE788

Phase 2

Brain and Central Nervous System Tumors

NVGH Vi-CRM197

Phase 2

Typhoid Fever

MenACWY-CRM197

Phase 2

Meningococcal Disease

GIA632

Phase 2

Atopic Dermatitis

MenACWY-CRM conjugate vaccine, adjuvanted

Phase 2

Prevention of Meningococcal Disease

CPK850

Phase 2

Retinitis Pigmentosa

LJN452

Phase 2

Primary Bile Acid Diarrhea

VAK694

Phase 2

Allergic Rhinitis

BAF312 solution

Phase 2

Hemorrhagic Stroke

Certoparin 3,000 IU Once Daily

Phase 2

Renal Insufficiency

Coartem

Phase 2

Acute Uncomplicated Plasmodium Falciparum Malaria

Surface Antigen, Inactivated, (Adjuvanted with MF59C.1), form. 2006-07

Phase 2

Influenza

BFH772 1% ointment

Phase 2

Erythemato-telangiectatic Rosacea

Atrasentan

Phase 2

IgA Nephropathy

LNA043

Phase 2

Osteoarthritis

Imatinib 600mg/day (Glevec is the brand name for imatinib)

Phase 2

Gastrointestinal Stromal Tumors

LOU064 Arm 1

Phase 2

Chronic Spontaneous Urticaria

[177Lu]Lu-PSMA-617

Phase 2

Metastatic Castration-Resistant Prostate Cancer (mCRPC)

RAD001(everolimus)

Phase 2

Carcinoma

68Ga-FAP-2286

Phase 2

Solid Tumor

Votoplam

Phase 2

Huntington Disease

Docetaxel

Phase 2

Advanced Gastric Cancer

H5N1 Influenza Vaccine

Phase 2

Prophylaxis of Avian Influenza

LFG316

Phase 2

Paroxysmal Nocturnal Hemoglobinuria

VAY736 1ml PFS

Phase 2

Sjögrens Disease

Sevelamer HCl

Phase 2

Chronic Kidney Disease

Seasonal Influenza Vaccine (MF59C.1)

Phase 2

Seasonal Influenza

Certican

Phase 2

Kidney Transplantation

Surface antigen inactivated influenza vaccine

Phase 2

Influenza

Dexamethasone based mouthwash

Phase 2

Advanced Breast Cancer

SMC021

Phase 2

Health Postmenopausal Women

NVA237 100 µg

Phase 2

Chronic Obstructive Pulmonary Disease (COPD)

FGF401

Phase 2

Hepatocellular Carcinoma (HCC)

KAE609

Phase 2

Malaria

MIJ821 Subcutaneous Injection 1 mg

Phase 2

Treatment-Resistant Depression

Vi-CRM197 vaccine

Phase 2

Typhoid Fever

Dovitinib (TKI258)

Phase 2

Tumor Pathway Activations Inhibited by Dovitinib

Tulmimetostat

Phase 2

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

sacubitril/valsartan (LCZ696)

Phase 2

Hypertension

NVA237 12.5 µg once daily

Phase 2

Chronic Obstructive Pulmonary Disease

Infliximab

Phase 2

Crohn's Disease

Glucocorticoids

Phase 2

ANCA Associated Vasculitis (AAV)

SAF312A

Phase 2

Postoperative Pain

Glycopyrronium bromide 25ug

Phase 2

Asthma

XXB750 drug

Phase 2

Resistant Hypertension

DTaP-Hib-IPV

Phase 2

Meningococcal Disease

indacaterol maleate / mometasone furoate

Phase 2

Asthma

XBD173

Phase 2

Anxiety Disorders

AHU377

Phase 2

Hypertension

Canakinumab (investigational)

Phase 2

Rheumatoid Arthritis

INE963

Phase 2

Uncomplicated Plasmodium Falciparum Malaria

Investigational new drug, company code: BGG492

Phase 2

Partial Onset Seizures

mometasone furoate

Phase 2

Asthma

GSK2118436

Phase 2

Cancer

CFZ533 - MMF - CS

Phase 2

Kidney Transplant Rejection

LCZ696A

Phase 2

Pharmacokinetics

alb-interferon alfa 2b

Phase 2

Chronic Hepatitis C

Cipargamin

Phase 2

Uncomplicated Plasmodium Falciparum Malaria

BZF961

Phase 2

Hepatitis C

PTK787/ZK 222584 (vatalanib)

Phase 2

Tumors

CFZ533

Phase 2

Lupus Nephritis

Capmatinib

Phase 2

Carcinoma, Non-Small-Cell Lung

Aliskiren 150 mg

Phase 2

Heart Failure

panobinostat

Phase 2

Relapsed and Bortezomib Refractory Multiple Myeloma

ABL001/Asciminib

Phase 2

Chronic Myeloid Leukemia (CML)

CAD106

Phase 2

Alzheimer Disease

rMenB+OMV

Phase 2

Healthy

Panobinostat (LBH589)

Phase 2

Myelodysplastic Syndromes

CLR325

Phase 2

Chronic Stable Heart Failure

LXH254

Phase 2

Melanoma

Serelaxin

Phase 2

Labor, Induced

Colchicine

Phase 2

Gout

Rapcabtagene autoleucel

Phase 2

Idiopathic Inflammatory Myopathies

Indacaterol 150 μg via the Concept1 dry-powder inhaler

Phase 2

Asthma

H5N1 pandemic Influenza vaccine 3.75µg

Phase 2

Pandemic H5N1 Influenza

GVV858

Phase 2

Advanced HR+/HER2- Breast Cancer

QAV680 + Cetirizine

Phase 2

Allergic Rhinitis

INC280

Phase 2

Non-small Cell Lung Cancer

Deferasirox granule formulation

Phase 2

Transfusion-dependent Anemia

Influenza vaccine surface antigen adjuvanted with MF59

Phase 2

Pandemic Influenza Disease

AAE581

Phase 2

Osteoporosis

Deferasirox dispersible tablet

Phase 2

Chronic Iron Overload Due to Transfusion-dependant Anemias

Daunorubicin

Phase 2

Acute Leukaemia

RLX030 (serelaxin)

Phase 2

Chronic Heart Failure

Dexamethasone

Phase 2

Immune Thrombocytopenia (ITP)

Naproxen

Phase 2

Osteoarthritis

Trivalent subunit inactivated flu vaccine, Formulation 2010-2011

Phase 2

Seasonal Influenza

Evolocumab

Phase 2

Atherosclerotic Cardiovascular Disease

TCH346 (dibenz[b,f]oxepin-10-ylmethyl-prop-2-ynyl-amine, hydrogen maleate salt)

Phase 2

Parkinson's Disease

Tropifexor (LJN452)

Phase 2

Non-alcoholic Steatohepatitis (NASH)

VHB937

Phase 2

Amyotrophic Lateral Sclerosis (ALS)

Rapcabtagene autoleucel single agent

Phase 2

Chronic Lymphocytic Leukemia

Iscalimab

Phase 2

Sjogren's Syndrome

RFB002

Phase 2

Diabetic Macular Edema

Pandemic influenza vaccine + seasonal influenza vaccine /pandemic influenza vaccine

Phase 2

Influenza

LXE408

Phase 2

Chagas Disease

AMO959

Phase 2

PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy

Surface Antigen, Inactivated, Adjuvanted Influenza Vaccine, Formulation 2007-2008

Phase 2

Influenza

Calcium carbonate/magnesium hydroxide/Lansoprazole 15 mg

Phase 2

Heartburn

Influenza Trivalent Inactivated vaccines Novartis

Phase 2

Influenza

Group B Streptococcus Trivalent Vaccine

Phase 2

Streptococcal Infection

SPP100

Phase 2

Hypertension

PTK787

Phase 2

Wet Age-Related Macular Degeneration

[177Lu]Lu-DOTA-TATE

Phase 2

Extensive Stage Small Cell Lung Cancer

Prednisone

Phase 2

Lupus Nephritis

LBH589

Phase 2

Lymphoma

Indacaterol acetate

Phase 2

Asthma

Lapatinib/nab-Paclitaxel

Phase 2

Neoplasms, Breast

ACZ885 (investigational)

Phase 2

Rheumatoid Arthritis

CFZ533 active - Cohort 1

Phase 2

Primary Sjögren's Syndrome

ARV-766 Part A&B

Phase 2

Prostate Cancer Metastatic

Anastrozole

Phase 2

Breast Cancer

MenACWY polysaccharide vaccine

Phase 2

Meningococcal Meningitis

AUY922 2 mg/m2

Phase 2

Breast Cancer

Iloperidone crystalline formulation

Phase 2

Schizophrenia

Ranibizumab 0.3 mg

Phase 2

Diabetic Macular Edema

NGI226

Phase 2

Achilles Tendinopathy

CNP520

Phase 2

Alzheimer's Disease

MenACWY-CRM Vaccine

Phase 2

Prevention of Meningococcal Disease

Influenza Trivalent Inactivated Vaccines

Phase 2

FLU

AEB071

Phase 2

Uveitis

Core Study: Deferasirox

Phase 2

Transfusional Iron Overload

Mometasone furoate/formoterol fumarate (MFF)

Phase 2

Asthma

RAF265

Phase 2

Metastatic Melanoma

serogroup B meningococcal vaccine

Phase 2

Meningococcal Disease

LDE225

Phase 2

Basal Cell Carcinoma

aTIV

Phase 2

Human Influenza

AIN457A

Phase 2

Ankylosing Spondylitis

Group B Streptococcus Trivalent Vaccine - 20/20/20 μg

Phase 2

Streptococcal Infections

Asciminib Pediatric formulation group

Phase 2

Myeloid Leukemia, Philadelphia Positive

Adjuvanted H5N1 pandemic influenza vaccine

Phase 2

Pandemic H5N1 Influenza

Prednisolone

Phase 2

Giant Cell Arteritis

Meningococcal (groups A, C, W, and Y) oligosaccharide diphtheria CRM-197 conjugate combined with meningococcal (group B) multicomponent recombinant vaccine

Phase 2

Meningococcal Disease

LCQ908A

Phase 2

Type 2 Diabetes Mellitus

Extended Release Methylphenidate (Ritalin LA ) plus Behavior Therapy

Phase 2

Attention Deficit Hyperactivity Disorder

BVS857

Phase 2

Spinal and Bulbar Muscular Atrophy

Montelukast

Phase 2

Asthma

AFQ056

Phase 2

Parkinson's Disease

MenABCWY

Phase 2

Meningococcal Disease

Patupilone

Phase 2

Metastatic Hormone Refractory Prostate Cancer

LHW090

Phase 2

Patients, Resistant Hypertension

QMF149 Twisthaler®

Phase 2

Asthma

NIC002

Phase 2

Smokers

rapcabtagene autoleucel (YTB323)

Phase 2

Progressive Multiple Sclerosis

RAD001, Letrozole 2.5mg

Phase 2

Breast Neoplasm

Flu Vaccine Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2008-2009

Phase 2

Influenza

HSC835

Phase 2

Acute Myelocytic Leukemia

LCI699

Phase 2

Hypertension

PDR001

Phase 2

Melanoma

QAX576

Phase 2

Asthma

Indacaterol 300μg

Phase 2

Chronic Obstructive Pulmonary Disease

SOM230

Phase 2

Dumping Syndrome

Lymphodepleting chemotherapy

Phase 2

Diffuse Large B-cell Lymphoma (DLBCL)

IV Artesunate

Phase 2

Severe Malaria

LIK066

Phase 2

Elevated Body Mass Index

Aliskiren/ Valsartan

Phase 2

Hypertension

MAS825

Phase 2

COVID-19 Pneumonia, Impaired Respiratory Function

CTL019 T-cells

Phase 2

B-cell Acute Lymphoblastic Leukemia

TKI258

Phase 2

Solid Tumors and Advanced Endometrial Cancer

Deferasirox (ICL670)

Phase 2

Chronic Anemia

MF59C.1-adjuvanted subunit influenza vaccine

Phase 2

Seasonal Influenza

QVM149 150/50/80 μg o.d.

Phase 2

Asthma

RHH646

Phase 2

Osteoarthritis, Knee

QBW251

Phase 2

Pulmonary Disease, Chronic Obstructive

BHQ880

Phase 2

Smoldering Multiple Myeloma

DNK333

Phase 2

Irritable Bowel Syndrome With Diarrhea (IBS-D)

BYM338

Phase 2

Skeletal Muscle

HCD122

Phase 2

Non-Hodgkin's Lymphoma

DNK333 100 mg twice daily

Phase 2

Chronic Obstructive Pulmonary Disease

Indacaterol (QAB149)

Phase 2

COPD

ECF843

Phase 2

Dry Eye

LBH589 (panobinostat)

Phase 2

Relapse/Refractory Multiple Myeloma

carboplatin

Phase 2

Advanced Triple Negative Breast Cancer (TNBC) With High TAMs

BGG492

Phase 2

Photosensitive Epilepsy

balicatib (AAE581)

Phase 2

Knee Osteoarthritis

Group B streptococcus vaccine

Phase 2

Streptococcal Infections

Novartis Meningococcal (MenACWY-CRM) vaccine

Phase 2

Meningococcal Disease

TIN816 70 mg lyophilisate powder

Phase 2

Acute Kidney Injury Due to Sepsis

MenC-CRM

Phase 2

Meningococcal Meningitis

NIM811

Phase 2

Chronic Hepatitis C Genotype-1 Relapse

NSAI: Letrozole or Anastrazole

Phase 2

Breast Cancer

Investigational Treatment

Phase 2

External Genital Warts

Iptacopan (part 1)

Phase 2

Lupus Nephritis

MF59-eH5N1

Phase 2

Pandemic

UNR844-Cl

Phase 2

Presbyopia

MenACWY Ad- (MenACWY-CRM, non adjuvanted formulation)

Phase 2

Prevention of Meningococcal Disease

Secukinmab

Phase 2

Rheumatoid Arthritis

rabbit anti-thymocyte globulin (r-ATG)

Phase 2

Severe Aplastic Anemia (SAA)

APL180

Phase 2

Coronary Heart Disease

Adjuvanted Trivalent Influenza Virus Vaccine (aTIV)

Phase 2

Human Influenza

LLG783

Phase 2

Peripheral Artery Disease (PAD); Intermittent Claudication

Seasonal Allergic Rhinitis

2 drugs in this indication

Chronic Plaque Type Psoriasis

1 drug in this indication

Cancer

1 drug in this indication

Myelodysplastic Syndromes

1 drug in this indication

Neovascular Age-related Macular Degeneration

1 drug in this indication

Hormone Receptor Positive Breast Cancer

1 drug in this indication

Pathological Myopia

1 drug in this indication

Renal Interstitial Fibrosis

1 drug in this indication

Non-Small Cell Lung Cancer

1 drug in this indication

Non-infectious Intermediate Uveitis

1 drug in this indication

Meningococcal Disease

1 drug in this indication

Prostatic Neoplasms

1 drug in this indication

Medulloblastoma

1 drug in this indication

Leukemia

1 drug in this indication

Melanoma

1 drug in this indication

Influenza

1 drug in this indication

Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)

Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply